Understanding Disease Modification in Atopic Dermatitis
Understanding Disease Modification in Atopic Dermatitis
Bekijk meer
StartpaginaArtikelen
Voor zorgverleners
Act early, think holistically for your patients with Type 2 diabetes at very high cardiovascular risk
People with type 2 diabetes and atherosclerotic cardiovascular disease face a high risk of cardiovascular events, yet many remain undertreated.1 The EASD/ADA 2022 and ESC 2023 guidelines for the management of type 2 diabetes urge early insulin initiation and intensive lipid lowering through a holistic approach. Managing both glycemia and lipids together is key to preventing CV events in people with type 2 diabetes.2,3
Bekijk meer
Understanding Autoimmune T1D & The Value of Early Detection
Autoimmune Type 1 Diabetes (T1D) can be detected through islet autoantibody testing years before symptoms appear.1-2 The video here explains how the condition progresses silently through presymptomatic stages, with beta cell destruction occurring long before symptom onset and clinical diagnosis.4-8
Bekijk meer
When a Child Gets Autoimmune Type 1 Diabetes
Parent's experiences of stage 3 diagnosis of T1D.
Bekijk meer
Sleep and QOL: the full impact on patients coping with the burden of AD
Understanding the full scope of AD—the unseen burden on patients.
Bekijk meer
Can autoimmune type 1 diabetes be detected years before symptom onset?
Autoimmune type 1 diabetes (T1D) is a progressive disease in which the decline in beta cell function usually begins months or sometimes years before clinical symptoms are observed.1–3 You can identify such patients at risk of developing autoimmune T1D before clinical symptoms are noticed by you or your patient.3
Bekijk meer
Does your patient have an existing autoimmune condition? Check for autoimmune type 1 diabetes!
Individuals living with other associated autoimmune diseases like celiac disease or autoimmune thyroid disease, are at an increased risk of developing autoimmune type 1 diabetes (T1D) and should be appropriately screened.1-6
Bekijk meer
Early detection of autoimmune type 1 diabetes could reduce the risk of diabetic ketoacidosis
Delay in screening for autoimmune type 1 diabetes (T1D) can increase the risk of diabetic ketoacidosis (DKA) at diagnosis—a critical complication that is potentially life-threatening and may result in long-term poor glycemic control and neurological complications.1,2 By identifying autoimmune T1D early, you can significantly lower the risk of DKA at diagnosis.3,4
Bekijk meer
How should individuals with positive autoimmune T1D autoantibodies be monitored over time?
Individuals who screen positive for ≥1 autoimmune islet cell antibodies need periodic medical monitoring, which includes regular assessments of blood glucose and HbA1c levels. You can also educate them about symptoms of diabetes, diabetic ketoacidosis (DKA), and provide psychosocial support to prepare them for a possible clinical diagnosis for type 1 diabetes (T1D).1
Bekijk meer